Found 78 clinical trials
-
Accepting Seniors
-
Accepting adults
-
10s of participants
-
An observational study
-
For all genders
-
Cardiology/Vascular Diseases
-
Currently Recruiting
Oral Anti-coagulants in Fragile Patients With Percutaneous Endoscopic Gastrostomy and Atrial Fibrillation (ORIGAMI) Pilot Study
Compelling evidences support the safety of direct oral anticoagulants (DOAC) compared to Vitamin K antagonists (VKA) in patients with non-valvular atrial fibrillation. The 2018 EHRA/ESC
- 6 views
- 26 Jan, 2021
- 1 location
-
Accepting pediatric ages
-
100s of participants
-
An observational study
-
For all genders
-
Pediatrics/Neonatology
-
Currently Recruiting
PIVKA-II Combined With Alpha-Fetoprotein for Diagnostic and Prognostic Value of Hepatic Tumors in Infants
efficiency of Protein Induced by Vitamin K Absence or antagonist-II(PIVKA-II) combining with alpha-fetoprotein in hepatic tumor of infant. This study is a multicenter study joined by several hospitals in
- 0 views
- 24 Jan, 2021
- 1 location
-
Accepting Seniors
-
Accepting adults
-
100s of participants
-
An observational study
-
For all genders
-
Cardiology/Vascular Diseases
-
Currently Recruiting
Perioperative Anticoagulant Use for Surgery Evaluation Emergency Registry
Among patients who are receiving long-term anticoagulant therapy, whether with a direct oral anticoagulant (DOAC) or vitamin K antagonist (VKA), approximately 3-5% who require treatment
- 5 views
- 23 Jan, 2021
- 3 locations
-
Accepting Seniors
-
Accepting adults
-
10s of participants
-
An observational study
-
For all genders
-
Currently Recruiting
Registry of Patient With Antithrombotic Agents Admitted to an Emergency Department
Antithrombotics with antiplatelet agents, vitamin K antagonist (VKA), heparin and related substances, and new oral anticoagulants are prescribed for arterial diseases, especially in secondary
- 0 views
- 21 Jan, 2021
-
Accepting Seniors
-
Accepting adults
-
100s of participants
-
An observational study
-
For all genders
-
Cardiology/Vascular Diseases
-
Currently Recruiting
Italian Registry In the Setting of AF Ablation With Rivaroxaban (IRIS)
standard therapy (direct vitamin K antagonists, VKA). In the specific case of the Rivaroxaban, several experimental trials have shown how the uninterrupted administration of the drug before the
- 0 views
- 25 Jan, 2021
- 1 location
-
Accepting Seniors
-
Accepting adults
-
100s of participants
-
An observational study
-
For all genders
-
Cardiology/Vascular Diseases
-
Currently Recruiting
Apixaban in Adults With Congenital Heart Disease and Atrial Arrhythmias: the PROTECT-AR Study
The purpose of this study is to evaluate the safety and efficacy of apixaban for the prevention of thromboembolism in adult patients with congenital heart disease (CHD) and non-valvular atrial arrhythmias (AA)
- 2 views
- 03 Feb, 2021
- 8 locations
-
Accepting Seniors
-
Accepting adults
-
100s of participants
-
An observational study
-
For all genders
-
Cardiology/Vascular Diseases
-
Currently Recruiting
Management of Atrial Fibrillation in Patients With Cancer (MAFIC Study)
The primary objective is to assess the safety and efficacy of switching from direct oral anticoagulants to low molecular weight heparin in cancer patients during antineoplastic therapy
- 20 views
- 25 Jan, 2021
- 2 locations
-
Accepting Seniors
-
Accepting adults
-
10s of participants
-
An observational study
-
For all genders
-
Family Medicine
-
Currently Recruiting
Bone Density and Vascular Calcifications Evolution After Renal Transplant
The investigators project is based on: Assessment of bone architecture by high resolution peripheral scanner (HRpQCT) and bone densitometry (DEXA); The non-invasive detection of vascular calcifications (by abdominal CT scanner) and bone abnormalities associated with kidney transplantation, as well as the analysis of their evolution over time; Longitudinal evaluation of …
- 0 views
- 28 Jan, 2021
- 1 location